Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2003, Vol. 8 ›› Issue (1): 18-22.

Previous Articles     Next Articles

Effects of insulin on expression of fibronectin, laminin and transforming growth factorβ1 in cultured neonatal rat cardiac fibroblasts

LIN Lan, HONG Hua-Shan, Chen Ruo-Han, WANG Yi-Bo, JIANG Qiong   

  1. Department of Cardiology, Union Hospital, Fijian Medical University &Fujian Institute of Coronary Heart Disease, Fuzhou 350001, Fujian
  • Received:2002-10-11 Revised:2002-10-26 Online:2003-02-26 Published:2020-11-25

Abstract: AIM: To study the effects of insulin on expression of fibronectin (FN), laminin(LN) and transforming growth factor β1 (TGFβ1) in cultured neonatal rat cardiac fibroblasts, and its role in induction of cardiac hypertrophy. METHODS: The neonatal rat cardiac fibroblasts were cultured and identified;the expressions of FN, LN and TGFβ1 in experimental group (insulin treatment group) of neonatal rat cardiac fibroblasts were compared with those in control group respectively by Streptavidin- Peroxidase (SP) method. RESULTS: The cultured cells showed the characteristic of morphology and immunocytochemistry of cardiac fibroblasts;the expression of FN on the cell membrane of cardiac fibroblasts in 10-8 mol·L -1 insulin treatment group increased significantly in comparison with control group (P <0.05);LN was hardly expressed on the cultured cardiac fibroblasts, and there was no difference between two groups;the expression of TGFβ1 in the cytoplasm of cardiac fibroblasts in 10-8 mol·L -1 insulin treatment group increased markedly compared to the control group. CONCLUSION: Insulin can promote FN expression on cardiac fibroblasts in vitro and may be involved in the pathogenesis of cardiac hypertrophy.The promotion of insulin on the synthesis and excretion of TGFβ1 in cardiac fibroblasts may account for this phenomena.

Key words: pharmacodynamics, insulin, fibroblast, fibronectin, laminin, transforming growth factor β1, cardiac hypertrophy

CLC Number: